<DOC>
	<DOCNO>NCT01571557</DOCNO>
	<brief_summary>This study evaluate relationship time since onset macular oedema symptom achievement vision gain patient prescribe OZURDEX速 . All care diagnostic procedure provide discretion participate physician accord clinical judgment local standard medical care .</brief_summary>
	<brief_title>A Safety Efficacy Study Assess OZURDEX速 Patients With Macular Oedema Secondary Retinal Vein Occlusion ( RVO )</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Diagnosis macular edema follow retinal vein occlusion Prescribed OZURDEX速 Previous treatment OZURDEX速</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>